The efficacy of Jazar capsule, on menopausal symptoms and sexual disorder of menopausal wome
- Conditions
- Menopausal symptoms and sexual disorder of menopausal women.Menopausal and female climacteric states
- Registration Number
- IRCT20180705040349N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 90
Married women that their spouses are present at home at least for half of each month
Age between 45-60
No menstrual periods for at least 12 months and no longer than 5 years
literate or having a literate person at home
Menopause but not due to illness or uterus and ovaries resection
At least 2 hot flashes per day
FSFI = 26
Willing to attend the project
Normal Pap smear during the last two years
Sensitivity to the medicine or placebo
Use of other medications or other therapies to reduce the menopausal symptoms during the study
Hormone intake for the past 6 months
Diabetes or other serious illnesses
Malignancy history
Addiction to cigarettes, drugs or alcohol
History of mental illness
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life. Timepoint: Weeks 4, 8 and 10 after intervention. Method of measurement: Menopause quality of life questionnaire (MENQOL questionare).;Sexual function. Timepoint: Weeks 4, 8 and 10th after intervention beginning. Method of measurement: Female sexual function index questionare (FSFI questionare).
- Secondary Outcome Measures
Name Time Method Vaginal maturation index (VMI). Timepoint: Before intervention and 10 weeks after intervention beginning. Method of measurement: Pap smear.;Vaginal PH. Timepoint: Before intervention and 10 weeks after intervention beginning. Method of measurement: PH-meter strip.